Researchers at the University of Virginia School of Medicine have overturned conventional wisdom on the workings of vital hormone receptors within cells, a finding that could boost drug development for diabetes and related metabolic disorders, cancer, and other diseases. The scientists in UVA’s Department of Pharmacology outline an entirely new paradigm to explain the activation...
